Companies: 10,795·Total market cap: $144.5T
Pharvaris N.V.

Pharvaris N.V.

PHVSNASDAQHealthcare● Active
$31.35
+$0.26(+0.82%)
Market Cap$2.2B
P/E Ratio
52W High$33.33
52W Low$15.91

Pharvaris N.V. (PHVS) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PHVS · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.12B$0.10B$0.07B$0.06B$0.04B
G&A Expenses$0.05B$0.05B$0.03B$0.03B$0.02B
Total Operating Expenses$0.17B$0.15B$0.10B$0.09B$0.05B
Operating Income($0.17B)($0.15B)($0.10B)($0.09B)($0.05B)
Operating Margin %(computed)
Interest Income$0.00B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.17B)($0.13B)($0.10B)($0.08B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.18B)($0.13B)($0.10B)($0.08B)($0.04B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.97$-2.48$-2.63$-2.27$-1.41
Wtd Avg Shares0.06B0.05B0.04B0.03B0.03B
EBITDA($0.17B)($0.15B)($0.10B)($0.09B)($0.05B)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B

Explore more Pharvaris N.V. data

About Pharvaris N.V. (PHVS) Income Statement

Pharvaris N.V. (PHVS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PHVS reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.18B) — a net profit margin of —.

Frequently asked questions

PHVS · 4 questions

Pharvaris N.V. (PHVS) reported revenue of $0.00B for 2025, down —% year-over-year.

PHVS revenuePHVS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08